Radiation from the images causes 5 percent of cancer cases, according to a new study. The doctor who made this grim discovery ...

Dirt for Monday, April 27, 2025 Were those days of our youth really that long ago? Well, yes they were  … Welcome to today’s ...

Pfizer’s sasanlimab, when used with standard of care, reduced the likelihood of disease recurrence or progression, death due ...

Oncologists at AUA 2025 share promising data, including sasanlimab, cretostimogene grenadenorepvec, and TAR-200 in NMIBC.

With an FDA review underway, Johnson & Johnson is aiming to “fundamentally change” how bladder cancer is treated. | With an ...

CG Oncology shares rose Monday after the company shared positive data from a study of its bladder-cancer treatment. The stock gained 39% to $31.10 in premarket trading.

Pfizer has linked its PD-1 inhibitor to a 32% reduction in the risk of disease-related events in a phase 3 bladder cancer ...

Shares of CG Oncology catapulted to a four-month high Monday after the biotech unveiled promising results for a Johnson & ...

Dunedin-based cancer diagnostic firm Pacific Edge has been dealt a severe financial blow after its key testing procedure was ...

Comedian Milton Jones has cancelled summer tour dates after revealing he's been diagnosed with prostate cancer.

(UroToday.com) The American Urological Association's 2025 Annual Meeting, between April 26 – 29, 2025 in Las Vegas, Nevada, was host to the Society of Urologic Oncology (SUO) Session. Dr. Bernard ...

Complete response (CR) observed in 79% (26/33) of evaluable patients with low-grade upper tract urothelial cancer (UTUC) who completed the Inductio ...